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DHDPS and DHDPR are the first two committed steps in the DAP pathway: a 
pathway responsible for the biosynthesis of lysine. It is only present in bacteria and 
plants making an important biological target. While DHDPS exists in a 
homotetrameric “dimer of dimers” formation in both bacteria and plants, the 
arrangement of monomers is different. In bacteria, the dimers face toward each other 
in a front to front arrangement. However, in plants, the orientation of the dimers is 
flipped into a back to back arrangement. An evolutionary difference is also observed 
in DHDPR. In bacteria, the protein exists in a homotetrameric conformation whereas 
in plants it has been shown to exist in a dimeric conformation. The exact reason for 
these differences in structure remain unclear but it is thought to due to evolutionary 
changes between the two organism types.  
 
In this study, a lycophyte DHDPS from Selaginella moellendorffii was found to exist 
in a substrate mediated equilibrium between dimer and tetramer, with no ligands 
bound. When the substrate pyruvate is bound to the enzyme, the equilibrium shifted to 
the tetrameric species. However, in the presence of the allosteric inhibitor lysine, the 
equilibrium was found to shift to a dimeric species in solution. This equilibrium could 
exist as a “missing link” in the evolution of the plant type quaternary structure of the 
DHDPS enzyme.  
 
Another subject of investigation was the characterisation of red, green and brown 
algal DHDPRs. The quaternary state of these species was found to be dimeric in 
nature. This corresponds to the proposed evolutionary lineage in which most of these 
species exist after the plant type species in the lineage. The exception to this is the 
green alga Chlamydomonas reinhardtii DHDPR which exists in an equilibrium 
between tetramer and dimer. As this organism lies in the evolutionary lineage 
between bacterial and plant forms, it is possible that this organisms DHDPR exists as 
the “divergence point” between these two species. C. reinhardtii DHDPR also 
contains a disulfide-dependent dimer interface. In the presence of reducing agent, the 
enzyme exists in an exclusively dimeric state. These evolutionary lineages could be 
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Chapter 1 – Introduction 
 
1.1  Overview 
 
The diaminopimelate (DAP) pathway is responsible for the biosynthesis of lysine in 
many lysine producing organisms. The first two committed steps in the pathway are 
catalysed by dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate 
reductase (DHDPR). Both proteins exhibit evolutionary differences dependent on the 
organism group. As lysine is an essential amino acid, the pathway is an important 
biological target which has many industrial and biological applications.  
 
1.2  DAP Pathway 
 
The diaminopimelate (DAP) pathway is responsible for biosynthesis of lysine in 
organisms such as bacteria, plants and lower fungi (Figure 1.1). Euglenoids and 
higher fungi use an alternate pathway known as the α-aminoadipate (AAA) pathway 
(Zabriskie and Jackson, 2000). AAA-like pathways have also been found in Thermus 
thermophilus and Pyrococcus horikoshii, a bacterium and an archaeon (Kobashi et al., 
1999, Kosuge and Hoshino, 1998). Animals do not contain either pathway and are not 




















At the beginning of the pathway, aspartate is phosphorylated by aspartokinase (LysC) 
to form L-4-aspartyl phosphate. This is reduced to form aspartate β-semialdehyde (S)-
ASA by aspartate semialdehyde dehydrogenase (Asd). These first two steps are also 
shared between methionine and threonine synthesis. DHDPS kicks off the first lysine 
specific step with an aldol condensation between (S)-ASA and pyruvate forming 2, 3 
dihydrodipicolinate (HTPA). DHDPR follows catalysing HTPA reduction to 2,3,4,5-
tetrahydrodipicolinate (THPA) using NADPH or NADH as a co-factor. 
 
At this point, the pathway branches off into four sub-pathways depending on the 
organism type. Succinylation is one branch that is found in proteobacteria and 
Mycobacterium tuberculosis (Usha et al., 2016, Fuchs et al., 2000). This involves the 
succinylation of THPA in a three-step process that adds two nitrogen groups to form 
L,L-2,6-Diaminopimelate, a lysine precursor which functions as the convergence 
point for 3 sub-pathways. 
 
Acetylation is another variation of the pathway. Using the same enzymes and steps as 
the succinylation pathway, this uses acetyl intermediates rather than succinyl ones. 
This pathway appears to be limited to certain Bacillus species (Sundharadas and 
Gilvarg, 1967). The third variation is the aminotransferase branch which directly 
converts THPA to the DAP precursor L,L-2,6-Diaminopimelate using 
diaminopimelate aminotransferase (DapL). This has been found in Cyanobacteria, 
Chlamydia, Methanococci, some archaea and Arabidopsis plants (Graham and Huse, 
2008, Hudson et al., 2006, Liu et al., 2010, McCoy et al., 2006). In all three of these 
variations, DAP epimerase (DapF) catalyses the conversion of L,L-2,6-
Diaminopimelate  to give meso-2,6-Diaminopimelate, a lysine precursor. 
 
The dehydrogenase variation directly forms meso-2,6-Diaminopimelate with NADPH 
and NH4
+ cofactors catalysed by diaminopimelate dehydrogenase (Ddh). This is 
found in selected Bacillus species and also in Corynebacterium glutamicum (Misono 
et al., 1979). In all variations of the pathway, meso-2,6-Diaminopimelate is converted 
to lysine by meso-diaminopimelate decarboxylase (LysA). While most organisms 
only have one sub-pathway present, some contain more than one such as C. 





Production of lysine is regulated by DHDPS feedback inhibition among other factors. 
Lysine can bind to an allosteric site on the DHDPS enzyme which causes inhibition 
(Hermann et al., 1972). This effect varies between organisms. Plant enzymes are 
typically much more susceptible to lysine inhibition than bacterial species (Griffin et 
al., 2012). In terms of bacteria, most Gram-positive species are lysine inhibited 
whereas a large proportion of Gram-negative species are not (Soares da Costa et al., 
2016). The exact physiological reason for these differing levels of regulation between 
species is unclear, but environmental factors and carbon availability may require a 
tighter regulation in these species.  
 
Another form of regulation is feedback regulation via aspartokinase (Rodionov et al., 
2003). In E. coli, high concentrations of lysine can repress transcription of the enzyme 
which functions as an alternative form of regulation in feedback insensitive DHDPS 
such as many Gram-negative bacteria. 
 
1.3  Importance of Lysine 
 
1.3.1  Industrial Production 
In 2011, the global amino acid market was valued at US$3.5 billion and predicted to 
rise to US$5.9 billion by 2018 (Research, 2015). To meet this growing demand, 
industrial production is of critical importance. In a three-step process, a suitable sugar 
source such as molasses or sucrose is fermented with a lysine excreting bacteria for 3 
to 5 days. The resulting broth is extracted and converted into a lysine powder through 
spray drying or crystallisation. This lysine can then be directly added to supplement 
animal feeds and other industrial uses. 
 
The soil bacterium Corynebacterium glutamicum is the main organism used to 
produce industrial lysine. Its safety, handling and viability in industrial conditions 
make it ideal for this purpose (Eggeling and Bott, 2015). After the discovery in the 
1950’s that it secreted amino acids, random mutagenesis and strain selection were 
used to create mutant bacteria with DHDPS that exhibited reduced lysine feedback 




mutations in their aspartokinase gene which resulted in significantly decreased 
feedback inhibition (Thierbach et al., 1990). Many also had decreased threonine 
production which positively affected lysine production. Unfortunately, random 
mutagenesis of genetic information from other parts of the organism led to limited 
viability and decreased stress tolerance. This led to the controversial creation of 
genetically modified organisms with increased lysine content. 
 
1.3.2  Importance in Nature 
As an amino acid, lysine is important for the synthesis of proteins and other 
biomolecules. In bacteria, meso-2,6-Diaminopimelate is a major component of 
peptidoglycan, a vital component of the bacterial cell wall in most bacteria. This 
compound is responsible for polymeric cross links which give the cell wall both 
strength and shape. This therefore makes the DAP pathway an important antibiotic 
target. 
 
Lysine produced by the DAP pathway is also significant in plants. While the pathway 
has been used as a herbicidal target, most investigation into the pathway in plants has 
been in search of higher lysine yields in crops (Watanabe et al., 2008, Dobson et al., 
2011). As lysine and methionine are the limiting amino acids in cereal and legume 
crops, this limits their nutritional values to 50 - 75% of regular diets containing 
balanced levels of amino acids (Galili et al., 2005, Galili and Amir, 2013). The use of 
higher lysine producing strains of such crops or supplementation from other sources 
may prove beneficial in providing more balanced diets. 
 
The recommended dietary intake in humans ranges between 30 and 64 mg/kg body 
weight/day for adults and infants, respectively. Typical western dietary intakes range 
between 40 - 180 mg/kg body weight/day with an upper limit of 300 - 400 mg/kg 
body weight/day (Tome and Bos, 2007). However, many developing countries utilise 
high cereal diets which do not contain sufficient lysine (Millward and Jackson, 2004). 
Deficiency of lysine and other essential amino acids have been linked to lowered 
disease resistance, decreased protein levels and growth development problems in 
children. Lysine also has more specific uses in humans such as the production of 
carnitine; an amino acid derivative involved in lipid metabolism (Vaz and Wanders, 




individuals that have special dietary requirements such as athletes, vegetarians and 
burn patients.  
 
Lysine is also important in the agriculture industry. It is the limiting amino acid in 
cattle and pigs while being the second limiting amino acid in poultry after cysteine 
and methionine (Richardson and Hatfield, 1978). Nursery pigs are required to ingest 
approximately 19 g of lysine per kg of gain (Mike Tokach, 2013). White egg laying 
hens aged between 0 and 6 weeks require 0.85 g of lysine each per day (Manuals, 
2016). This makes the supplementation of animal feeds with industrially produced 
lysine important to ensure health and growth of livestock. 
 
1.4  Applications and Aims 
 
1.4.1  Applications 
With knowledge of lysine regulation mechanisms, synthesis of a genetically 
engineered organisms with DAP pathway modifications produced higher amounts of 
lysine. This is normally done through insertion of feedback insensitive DAP pathway 
enzymes such as DHDPS from feedback insensitive C. glutamicum strains have led to 
creation of soy, canola and maize variants with increased lysine content (Falco et al., 
1995, Zhu et al., 2007). Another target is aspartokinase regulation. A point mutation 
at a specific position in aspartokinase was found to increase lysine production (Xu et 
al., 2016). The lysine exporter protein LysE is also targeted to increase lysine 
production (Gunji and Yasueda, 2006). This protein transports lysine out of the cell 
and is also thought to serve as a fail-safe against excessive lysine levels. Increased 
production of this protein is thought to lead to an increased efflux of lysine from the 
organism. The introduction of genetic modifications to commercially available strains 
of organisms, such as maize, remains controversial as the creation and use of 
genetically modification organisms is a highly debated ethical issue. 
 
While there is ongoing investigation into industrial production in bacteria and plants 
as industrial sources of lysine, there are other possible organisms whose DAP 
pathway remain relatively unstudied. One such example is the use of algae as a 




investigation with applications ranging from biofuel to hydrogen production, as well 
as environmental applications. This may prove to be a possible avenue of 
investigation into the industrial production of lysine as well as a target for algicides. 
 
The DAP pathway has been proposed as an antibiotic or herbicidal target due to its 
absence in humans. Enzymes such as DHDPS and DapL have been investigated as 
possible targets in both plants and algae (Dobson et al., 2011). As these enzymes 
catalyse the first and last steps of the pathway, these enzymes are the most 
characterised in the pathway. They also catalyse steps that are present in all sub-
branches of the pathway. However, there are many other enzymes in the pathway 
which could present themselves as attractive targets, such as DHDPR. Further 
characterisation of DHDPR could lead to a potential biological target. 
 
1.4.2  Aims 
While DHDPS has been characterised extensively in bacteria and plants, it remains 
relatively unstudied in lycophytes. One of the aims of this study is to purify and 
characterise DHDPS from the lycophyte Selaginella moellendorffii. This may give an 
insight into the differences in quaternary structure between bacteria and plants and 
may serve as a probe into the evolutionary mechanism of the protein.  
 
DHDPR on the other hand is considerably less characterised. Only bacterial DHDPR 
crystal structures exist so far with only one plant DHDPR characterised. The other 
aim of this study is to characterise red, green and brown algal DHDPR enzymes. 
Characterisation of these species could lead to industrial or algicidal applications in 
these organisms. This study will also provide possible insight into their quaternary 
structure and may characterise a “divergence point” between bacterial and plant type 











Chapter 2 – Methods and Materials 
 
2.1  Materials 
 
2.1.1  Chemicals 
All chemicals used were purchased from Lab Supply, Sigma Aldrich and Thermo 
Fisher. Crystal screens were purchased from molecular dimensions. 
 
2.1.2  Equipment 
An Äkta FPLC was used for all protein purifications. Vivaspin 2 10,000 Da 
concentrators were used to concentrate proteins prior to characterisation.  
 
2.2  Purification  
 
2.2.1  Plasmid Selection 
All plasmids were purchased from Epoch Biolabs. Sequences were found using the 
UniProt protein sequence database. Algal plasmid sequences were selected through an 
NCBI BLAST search in comparison with either E. coli or A. thaliana DHDPR. 
Transformation of these plasmids into BL21 E. coli competent cells was performed 
using standard lab protocols prior to the start of the project. 
 
2.2.2  Protein Purification 
Transformed cells containing the plasmid were inoculated into 5-10 ml of sterile LB 
and incubated overnight. The culture (Table 2.1), antibiotics (Table 2.2) and 
remaining media components (Table 2.3) were added to 400 – 800 ml of autoclaved 
M9ZB media leaving about 1 ml remaining in case of negative result. The flasks were 
then incubated at 37 ºC spinning at 180 - 220 RPM until the optical density at 600 nm 
(OD600) reached ~0.6. This required 3 - 5 hours depending on the pre-culture and 
media volumes. These cultures were incubated at 26 °C and induced with a 1/1000 
dilution of 0.21 mol/L (50 mg/ml) IPTG. Cultures were left at 26°C spinning at 180-






Table 2.1: The components of M9ZB media. 






Yeast Extract 5 
 
Table 2.2: The initial concentrations of antibiotics to be added to the M9ZB media. 









Glucose 2.22 1/100 
Antibiotic See Table 2.2 1/1000 
MgCl2 0.4 1/1000 
 
 
Following incubation, the cultures were centrifuged at 8,000 RPM for 5 minutes. The 
resulting cell pellet was then resuspended in 15 ml of His Tag Buffer A (Table 2.4) 
through vigorous shaking. Resuspended cells were lysed on ice for 20 minutes using 









Table 2.4: The components of the two His Tag Buffers used during His Tag 
chromatography. 
Component His Tag Buffer A (mM) His Tag Buffer B (mM) 
Na2HPO4 50 50 
Imidizole 30 300 
NaCl 500 500 
pH 8.0 8.0 
 
The cell lysate was centrifuged again at 16,000 RPM for 15 minutes to separate debris 
from the lysate. A Ge Health Care Life Sciences HisTrap FF column was prepared by 
flowing 15-30 ml (3-6 column volumes) of His Tag Buffer B to remove any proteins 
that may have remained bound from prior column use. The column was then prepared 
washing through 10 ml of His Tag Buffer A before the lysate was injected into the 
super loop and onto the column. Once the lysate had been completely injected, His 
Tag Buffer A was flowed through to wash unbound proteins from the column. At this 
point, His Tag Buffer B was flowed through the column to elute the protein of interest 
from the column into 1.5 ml fractions. These fractions were selected based on UV 
absorbance and pooled before buffer exchange. A Ge Health Care Life Sciences 
HiPrep 26/10 Desalting column was used to exchange the protein into a Tris buffer 
(Table 2.5) depending on the proteins salt preference.  
 
Table 2.5: The Tris Buffers the proteins were stored in. 
Component Tris Buffer 
 (Low Salt) 
Tris Buffer 
(High Salt) 
Tris-Base 20 mM 20 mM 









2.3  Size Exclusion Chromatography 
 
2.3.1  Qualitative Size Exclusion Chromatography  
Prior to SEC, protein samples were concentrated to a volume between 0.5 – 1.5 ml. A 
Ge Healthcare Life Sciences Superdex 200 column was prepared with ~30 ml (1.25 
column volumes) of the desired Tris buffer. The sample was injected and protein 
fractions were eluted out and collected in 0.5 ml fractions. Fractions that showed 
higher UV absorbance were pooled on a peak by peak basis. 
 
2.3.2  Quantitative Size Exclusion 
To quantitatively run size exclusion chromatography, a Ge Healthcare Life Sciences 
Superdex 200 column was prepared with ~30 ml of the corresponding Tris buffer 
(Table 2.5). A protein sample of 1 ml was loaded into the sample loop using a syringe 
and injected into the column. The activity of each fraction was quantified using the 
kinetic assay (Chapter 2.6) to check for DHDPR activity.  
 
2.4  SDS-PAGE Gel 
 
Samples were prepared in accordance to Table 2.6. Samples along with one lane 
consisting of Novex Sharp Pre-Stained Ladder were added to a Novex Bolt 4-12% Bis 
Tris Plus gel submerged in a 1x dilution of MES buffer in a gel tank. The gel 
electrophoresis was set to run at 166V for 35 minutes.  
 
Table 2.6: The contents of the samples for the SDS PAGE gel 
Component Amount (μl) 
LDS Loading Dye 2.5 μl 
Protein Sample 1-5 μl 
Water  2.5-6.5 μl 







2.5  Analytical Ultracentrifugation 
 
Analytical Ultracentrifugation (AUC) experiments were carried out using a Beckman 
Coulter XL1 protein characterisation system. Sample cells were made up with 400 μl 
of protein sample and 380 μl of buffer was used in the reference well. These were run 
at a speed of 50,000 RPM at 20 °C. The number of runs and wavelengths were varied 
depending on the protein sample.  
 
2.6  Kinetic Assays of DHDPR 
 
The kinetic assay of DHDPR was adapted from (Reddy et al., 1995). Assay samples 
were made using the components in Table 2.7. 
 







HEPES (pH 8.0) 100 mM 850 81.73 mM 
NAD(P)H 3.24 mM 50 0.156 mM 
DHDPS ~1 mg/ml 20 ~0.005 mg/ml 
(S)-ASA 40 mM 50 1.92 mM 
Pyruvate 1 – 40 mM 10-50 0.048 – 1.92 mM 
DHDPR ~1 μg/ml 20  
Total  1000-1040  
The spectrophotometer was equilibrated to read absorbance at 340 nm (NAD(P)H 
oxidation wavelength). To equilibrate the correct concentration of DHDPR, an 
undiluted sample of DHDPR was added to the assay. If the rate was not linear, the 
enzyme was diluted with buffer until the rate remained linear during the entire assay 
time. This concentration was usually around 1 - 10 μg/ml but be higher or lower 
depending on the effectiveness of the enzyme. Cuvettes containing HEPES, DHDPS 




temperature. Once equilibrated, pyruvate was added and the cuvette was mixed by 
pipetting the contents up and down several times. After 3 minutes, NAD(P)H was 
added and the cuvette was mixed again. At this point, data collection began and the 
rate was checked to ensure no background activity.  After 5 minutes, DHDPR was 
added to initiate the assay. The initial rate was measured in mAU through the linear 
drop in nucleotide absorbance over time. This allowed for the calculation of kinetic 
parameters of the substrate whilst the enzyme utilised either NADH or NADPH such 
as the Km, Vrel and V/Km. 
 
2.7  Small Angle X-ray Scattering 
 
Measurements were carried out at the Australian Synchrotron small angle scattering 
(SAXS) beamline with a Pilatus 1M detector (169x179 mm; pixel size 172x172 μm). 
The X-ray wavelength was 1.0322 Å. Protein samples were filtered and concentrated 
to ~4 mg/ml prior to elution through a Superdex 200 Increase 3.2/300 column 
immediately before data collection to remove any protein aggregates. Data was 
collected using a glass capillary at 20 °C in 2 second intervals. Intensity plots were 
radially averaged, normalised and background subtracted using the Scatterbrain 
program in the ATSAS suite (Petoukhov et al., 2012).  
 
Guinier analysis was carried out using PRIMUS (Konarev et al., 2003). Porod 
volumes were calculated using GNOM (Svergun, 1992). GNOM was also used to 
generate the real space function P(r) using an indirect Fourier transform. Comparison 
of experimental and theoretical scattering curves was achieved using CRYSOL 
(Svergun et al., 1995). GASBOR was used to create ab initio models using a dummy 
residue model (Svergun et al., 2001). 
 
2.8  Differential Scanning Fluorimetry  
 
Differential scanning fluroimetry (DSF) was carried out on an Applied Biosystems 
QuantStudio 3 Real-Time PCR System. Each reaction condition (100 μl) was split 
into four 25 μl samples and placed in separate wells on a PCR plate on ice. The 




the system reached 100 °C. The data was fitted to a Boltzmann derivative model using 






Chapter 3 – DHDPS 
 
3.1   Background  
 
3.1.1  Quaternary Structure and Mechanism 
DHDPS has been highly characterised due to its position and role in regulation of the 
DAP pathway. The enzyme typically exists in a homotetrameric conformation 
consisting of four identical subunits in most organisms (Figure 3.1). These individual 
subunits exist as a classic TIM barrel fold. This lyase catalyses the first committed 
step in the DAP pathway; a condensation reaction between (S)-ASA and pyruvate to 
form the product HTPA and a water molecule. 
  
 
Figure 3.1: E. coli and A. thaliana crystal structures of DHDPS with key regions 
labelled. 
 
Kinetically, the reaction exists as a ping pong mechanism. The proposed mechanism 




by Lys 161 which forms a Schiff base. (S)-ASA subsequently binds and is dehydrated 
and cyclised forming the final product, HTPA. The specific importance of Lys 161 in 
the mechanism was tested through alanine and arginine mutants which modified the 
side chain position of the catalytic nitrogen. These mutants were found to be 
catalytically active with a slight decrease in activity (Soares da Costa et al., 2010). It 
was speculated that in step one, the enol form of pyruvate in equilibrium can function 
as an enamine in the reaction mechanism. This would allow pyruvate itself to attack 
the proton from Tyr 107 which may mean that Lys 161 may not have as big a role as 






Figure 3.2: The mechanism of DHDPS (adapted from (Dobson et al., 2005a)) 
 
3.1.2  Key Residues 
It is widely accepted that DHDPS contains three crucial residues located between two 
subunits interface. Known as the “catalytic triad”, these residues form a proton shuttle 
from the solvent outside the protein to the active site (Figure 3.3). The first such 
residue is Tyr 133 (E. coli numbering). This residue sits directly above Lys 161 and is 
proposed to have a role in step 1 of the mechanism (Dobson et al., 2004). Mutation to 
a glutamic acid resulted in a 99.7% drop in activity compared to wild type (Dobson et 
al., 2004). The specific placement of the residue allows binding to the hydrate of (S)-
ASA and proton donation to occur. 
 
Figure 3.3: The catalytic triad of E. coli DHDPS active site residues: Thr 44, Tyr 133 








Another critical residue in the catalytic triad is Thr 44. Located adjacent to Lys 161, it 
is hydrogen bonded to the two other catalytic triad residues forming a proton shuttle 
(Dobson et al., 2004). While the residue is not suggested to be directly involved in 
substrate binding, it appears to play a part in Schiff base formation mechanistically 
stabilising Tyr 133 through hydrogen bonding (Blickling et al., 1997). This was tested 
with a mutation to a valine which resulted in a 99.9% drop in maximum rate but no 
change in affinity for either substrate (Dobson et al., 2004). A slight change in Tyr 
107 location was also observed which rendered the enzyme much less catalytically 
active. While it was speculated that a mutation to a serine would establish activity due 
to its retained hydroxyl group , it was only restablished to 8% of the wild type and the 
mechanism was modified to a ternary complex mechanism with a trapped α-
ketoglutarate adduct in the active site (Dobson et al., 2009) (Figure 3.4). This adduct 
has also been observed in various dimeric and catalytic triad mutants causing 
speculation that flexibility of active site residues can reduce specificity and cause 
other similar molecules to bind the enzyme instead (Reboul et al., 2012). 
 
 
Figure 3.4: The mechanism of formation of the α-ketoglutarate adduct formed in 
certain dimeric DHDPS mutants (adapted from (Dobson et al., 2009)) 
 
The final residue in the catalytic triad is Tyr 107. This residue appears to contribute to 
the tight binding interface of the dimers while also playing a role in the proton shuttle 
between the active site and solvent similar to Thr 44 (Blickling et al., 1997, Dobson et 
al., 2004). Phenylalanine mutation of the residue altered the positioning of the relay-
stabilising hydroxyl group causing a tenfold loss of activity which was not as 
pronounced as the other triad mutations (Dobson et al., 2004). This may be due to the 
positioning of the residue in a channel leading to the dimer interface. A water 




107 would have been to partially fulfil its role (Dobson et al., 2004, Griffin et al., 
2008).  
 
While the triad residues are most important in its mechanism, there are other 
important residues key to enzyme activity. Arg 138 is one such residue sitting at the 
active site entrance (Dobson et al., 2005a). Highly conserved among DHDPS, its role 
appears to be in binding (S)-ASA and stabilising the proton relay. Its importance was 
tested through the creation of two mutants; R138H and R138A. The histidine mutant 
retains the steric bulk and basic activity of the arginine but removes direct interactions 
with the substrate, and the alanine mutant removes all side chain functionality 
previously present. Both mutants display greatly decreased substrate affinity and 
catalytic function showing that specificity for arginine at this position is critically 
important to catalysis. The R138A mutant specifically causes the three catalytic triad 
residues to exist in several different conformations, increasing flexibility and 
distances between residues in the hydrogen bonding network.  
 
Ile 203 is also thought to play a role in catalysis in E. coli DHDPS (Dobson et al., 
2008). This residue binds to a hydroxyl group of the substrate analogue β-
hydroxylpyruvate. The residue also has a highly strained torsion angle of 201° which 
is greater than four standard deviations from the average torsion angle. It is speculated 
that the residue could play a role in the mechanism (Dobson et al., 2008). 
 
3.1.3  Dimeric Interfaces 
The interdimer interface is the smaller dimer interface responsible for holding the 
tetrameric structure together along with reducing protein dynamics. In E. coli, the 
total contact area of the solvent accessible surface area of the inter dimer interface is 
4.8% compared to the 11.2% in the intra dimer interface (Dobson et al., 2009). This 
has given rise to the terms “tight” and “loose” dimer interfaces for the intra-dimer and 
inter-dimer interfaces, respectively.  
 
Several residues present at the inter-dimer interface are critical in its interactions. Leu 
196 is a residue that contacts the equivalent leucine from the neighbouring subunit 
through hydrogen bonding (Dobson et al., 2009). Mutation to a negatively charged 




electrostatic repulsion between monomers forming a dimer-tetramer equilibrium in 
solution. The adjacent residue, Leu 197, is also important in the stability of the 
interdimer interface (Griffin et al., 2008). Mutation of the residue to an aspartic acid 
also led to dimeric variants and greatly reduced activities compared to the wild type 
(1.4% and 2.5% respectively). 
 
Asp 193 is another important residue in the interface. It hydrogen bonds with water 
molecules that occupy cavities in the interface (Dobson et al., 2009). Substitutions of 
the residue with alanine and tyrosine removed hydrogen bonding interactions and in 
the case of tyrosine, introduced steric hindrance. These mutations both led to a dimer-
tetramer equilibrium in solution. Glu 234 and Glu 175 also form cross interface 
contacts with each other. When these residues were replaced with a negatively 
charged aspartic acid, electrostatic repulsions similar to the Leu 196 mutant formed a 
dimer-tetramer equilibrium. This was not to as great of an extent as the Leu 196 and 
Asp 193 mutations, indicating that this interaction is less important than these 
residues. 
 
The larger intradimer interface is of critical importance to the lysine inhibition 
mechanism due to its proximity to the binding site. Crystallised E. coli DHDPS with 





Figure 3.5: Binding region for lysine at the intradimeric interface in E. coli. The five 
critical residues (yellow) shown from each monomer that bind lysine (shown in red) 
are: Ala 49, His 56, Asp 80, Glu 84 and Tyr 106.  
 
Comparison of a lysine insensitive DHDPS from C. glutamicum with E. coli DHDPS 
showed several differences in the residues involved in lysine binding (Rice et al., 
2008). In E. coli, seven amino acid residues are important in stabilisation of lysine at 
the binding site. However, in C. glutamicum, key differences prevent these 
interactions. His 56 (Lys 71 in C. glutamicum) hydrogen bonds to lysine in E. coli but 
the equivalent residue in C. glutamicum DHDPS does not. It is thought that this is the 
key residue in determining whether the enzyme undergoes lysine inhibition or not 
(Soares da Costa et al., 2016). If a glutamic acid or histidine is present, lysine binding 
can occur but a lysine or arginine in this position stops lysine binding due to a lack of 
side chain interactions. Mutation of His 56 in E. coli to its C. glutamicum counterpart 
along with Glu 84 was found to remove lysine inhibition (Geng et al., 2013). His 53 
appears to be another important residue in E. coli which acts as a “lid” which 




was too small to serve the same function. Glu 48 in was also found to be important in 
E. coli. This residue hydrogen bonds with the substrate lysine but the equivalent Thr 
99 in C. glutamicum DHDPS does not have a long enough side chain to provide the 
same function. 
 
Monomeric mutant DHDPS have also been created using a combination of both inter 
and intra dimeric dissociation (Muscroft-Taylor et al., 2010). A dual Y107F/L197D 
mutant was found to exist as a monomer in size exclusion chromatography and 
analytical ultracentrifugation. This variant also had greatly reduced activity (8% of the 
wild type) with the ternary complex mechanism due to triad disruption and did not 
undergo lysine inhibition. This shows the importance of the quaternary structure in 
lysine inhibition. 
 
3.1.4  Lysine Inhibition Mechanism 
It has been speculated that lysine mediated DHDPS inhibition is a result of disruption 
of the catalytic triad proton relay. This is thought to be caused by Tyr 107 
displacement instigated by movement of its neighbouring Tyr 106 in E. coli (Dobson 
et al., 2005b). This is also observed in the plant DHDPS Vitis vinifera where a 
rearrangement of the neighbouring hydroxyl group in Tyr 131 (Tyr 106 in E. coli) 
causes displacement in the neighbouring catalytic triad residue Tyr 132 (Tyr 107 in E. 
coli) disrupting the proton relay and inhibiting the enzyme (Atkinson et al., 2013). 
 
Another example of lysine inhibition is in the Gram-negative bacteria Campylobacter 
jejuni DHDPS. Binding of lysine shows domain movement of residues 104-184 
(Conly et al., 2014). Tyrosine residues 110 and 111 (106 and 107 in E. coli) were 
found to be critical in this domain movement. A Y110F mutant removed the domain 
movement and substantially reduced inhibition. Active site size also appears to play a 
role in lysine regulation (Conly et al., 2014). When pyruvate bound to the apo form of 
DHDPS, the active site volume decreased by 44% and the allosteric site volume by 
16% compared to the lysine bound form which increased the active site volume by 
30%. The Y110F mutant did not have these changes in volume further showing the 






3.1.5  DHDPS as a Drug Target 
As the first committed step in the DAP pathway, inhibition of DHDPS through small 
molecules could be a viable drug target. However, this would only be the case if high 
levels of both specificity and inhibition could be assured (Hutton et al., 2007). Most 
attempts to achieve this have been through the construction of DHDPS substrate (S)-
ASA analogues. While many heterocyclic compounds that covalently bind to the 
enzyme were found to be effective in inhibiting activity, only a few show any form of 
specificity (Mitsakos et al., 2008). Chelidamic acid and its diester were found to 
potently inhibit E. coli, M. tuberculosis and S. aureus DHDPS but did not inhibit B. 
anthracis DHDPS. Other compounds such as piperidine ester and thiazanes inhibited 
E. coli and B. anthracis DHDPS much more strongly than M. tuberculosis and S. 
auerus DHDPS (Mitsakos et al., 2008).  Antibacterial activity of each compound 
exhibited various levels of success showing the potential for future development of 
inhibitors. It has also been noted that partial enzyme activity has been observed with 
some DHDPS substrate analogues (Devenish et al., 2010). Substrates with an 
electronegative substituent in the 3’ position were found to be compatible with the 
enzyme but at a significantly lower rate than (S)-ASA. This information could be used 
to create new inhibitors which could covalently bind or block further pathway 
enzymes such as DHDPR. 
 
There have been other recent developments in targeted inhibitors for DHDPS. A 
molecule known as 2-methylheptyl isonicotinate (2MHI) was isolated from 
Streptomyces sp. 201 (Singh et al., 2012). This molecule was found to form 
favourable interactions with binding sites in M. tuberculosis and exhibit anti-bacterial 
activity. Another recent development has led to creation of a novel DHDPS inhibitor 
known as “bislysine” (Skovpen et al., 2016). This molecule effectively exists as two 
lysine molecules linked together by an ethylene bridge between its α-carbon binding 
in two binding sites at the same time. This inhibitor was found to bind Campylobacter 








3.2  Evolutionary Differences 
 
DHDPS has a significant evolutionary structural difference between bacteria and 
plants. While it is known that the plant version exists in a different arrangement of 
monomers to the bacterial protein, it is uncertain why this change occurs. These 
differences can be explained by the proposed evolution of its quaternary structure 
(Griffin et al., 2008). It is hypothesised that the enzyme first existed as a monomer 
containing a catalytic dyad made up of the two residues from the individual monomer; 
Tyr 133 and Thr 44. To fill the role of Tyr 107, an ordered water molecule is thought 
to complete the reaction. However, this reaction could be optimised through the 
addition of Tyr 107 from another monomer to form a dimer and complete the triad. 
However, this setup is still not optimal as this dimer would suffer from small 
“breathing” movements of residues which reduces substrate specificity and catalytic 
efficiency. Specifically, movement of Tyr 107 causes the hydrogen bonding network 
to become more strained, negatively affecting catalysis. Formation of a tetramer from 
two dimers would prevent excessive dynamics increasing rate and substrate 
specificity. However, this tetramer could be formed in either front or back facing 
formations leading to the differing monomeric orientations between plants and 
bacteria.  
 
There are special cases of DHDPS that do not adhere to the typical tetrameric 
structures. These include the dimeric DHDPS of S. auerus, P. aeruginosa and L. 
pneumophila (Burgess et al., 2008, Kaur et al., 2011, Soares da Costa et al., 2016). 
While dimeric mutants of tetrameric DHDPS are not catalytically optimal due to 
“breathing” motions, these native dimeric enzymes exhibit similar activity and 
specificity to their tetrameric counterparts. A much more extensive intradimeric 
interface is observed which has a greater solvent inaccessible surface area than other 
DHDPS. While E. coli was found to have 7 residues involved in hydrogen bonding 
and 3 involved in hydrophobic contacts at the intradimeric interface, dimeric S. 
auerus DHDPS has 17 residues involved in hydrogen bonding and 18 hydrophobic 
contacts (Burgess et al., 2008). This makes S. auerus much more effective as a 





There are also other interesting differences between S. aureus and E. coli DHDPS. 
One of the catalytic triad residues Tyr 109 (Tyr 107 in E. coli) has a significantly 
different orientation in which the aromatic ring of the tyrosine is rotated by 60°. This 
gives a more tightly packed aromatic stacking interaction, eliminating the need for a 
tetrameric structure. A similar movement of a catalytic triad residue was observed in 
P. aeruginosa DHDPS (Kaur et al., 2011). Tyr 133 was found to have rotated 46° 
compared with E. coli. This may have a similar effect to S. auerus DHDPS in keeping 
the aromatic stacking interactions more tightly packed than in typical tetrameric 
DHDPS. 
 
3.3   SMO DHDPS Sequence Analysis 
 
Selaginella moellendorffii is an ancient lycophyte that is commonly used in 
comparative genomics as a model organism. Due to its location on the evolutionary 
lineage as the oldest extant division of vascular plants, it is an ideal target organism to 
characterise the evolution of both bacterial and plant type DHDPS enzymes.  
 
To help ascertain whether SMO DHDPS exhibits properties similar to other DHDPS 
enzymes, its sequence was compared to a bacterial type E. coli and a plant type A. 





Figure 3.6: Sequence alignment of E. coli, A. thaliana and S. moellendorffii DHDPS. 
Catalytic triad residues are indicated in blue, other catalytic residues in orange and E. 
coli lysine binding residues are shown in green. 
 
The sequence alignment shows many conserved residues from both E. coli and A. 
thaliana DHDPS. All three catalytic triad residues (Thr 44, Tyr 107 and Tyr 133) are 
conserved along with other residues thought to be important such as Lys 161, Gly 186 
and Ile 203. The enzyme was found to exhibit typical DHDPS activity with tight 
lysine inhibition similar to other plant DHDPS enzymes (unpublished data). One 
minor difference is observed in the major lysine binding residues. In E. coli, Ala 49 is 
thought to be involved in lysine binding (Soares da Costa et al., 2016). However, in 
both A. thaliana and S. moellendorffii the residue is altered to a glutamine and 
histidine respectively. This may partial account for the tighter lysine inhibition in 
plant type DHDPS enzymes. All three sequences were found to contain the critical 







3.3  Transformation, expression and purification of SMO 
DHDPS 
 
The plasmid containing the gene for SMO DHDPS was transformed into E. coli BL21 
DE3 cells using standard lab protocols prior to purification. The enzyme was purified 
using the techniques described in the methods. This produced 25.8 mg of protein from 
1.8 L of media. The protein was stored in “low salt” 20 mM Tris and 150 mM NaCl 
buffer.  
 
3.4  Analytical Ultracentrifugation  
 
Analytical ultracentrifugation (AUC) is a technique which measures the real-time 
sedimentation of a protein solution under a centrifugal force. This gives information 
about the protein such as the mass and shape. In this context, it can be used to test the 
molecular mass of SMO DHDPS while bound to lysine and pyruvate, as well as no 
ligand which allows the quaternary state of the protein to be determined (Figure 3.7).  
 
Figure 3.7: AUC data from SMO DHDPS in solution under 3 different conditions. 
 
With no ligand present, it could be hypothesised that the protein exists not in a dimer 
nor a tetramer but in an equilibrium of the two forms. The single peak at ~5.7 S is 
observed. This value can be converted to an approximate molecular weight using the 
Svedberg equation. This equates to an estimated molecular weight of ~99,000 Da. 
With the theoretical monomer weight calculated to be 40,713 Da, this indicates a 
dimer-tetramer equilibrium or a trimeric species. However, the long broad peak 




protein is constantly switching between dimeric and tetrameric conformations. As this 
is not two separate species in solution, this only appears as one peak in the graph.  
 
The lysine bound form exhibits a major peak at ~4.8 S which equates to an estimated 
molecular weight of ~77,000 Da. This information indicates that the protein forms a 
dimeric species in the presence of lysine.  
 
With a sedimentation coefficient of ~7 S, the pyruvate bound species has an estimated 
molecular weight of ~135,000 Da which is consistent with a tetrameric protein in the 





3.5  Small Angle X-ray Scattering 
 
In order to confirm the shape of the protein in solution, small angle X-ray scattering 
(SAXS) was used. The scatter patterns of SMO DHDPS can be compared with model 
bacterial and plant DHDPS and Chi2 fits compared.  
 
 
Figure 3.8: Intensity plot (log I vs S) (a) and distance distribution plot (P (R)) (b) for 
















E. coli DHDPS 1.60 




The SAXS data shows interesting insights into the nature of both lysine and pyruvate 
bound SMO DHDPS.  The P(R) plot can show information about the proteins 
quaternary structure. This plot measures the paired set of distances between points. 
The P(R) plot for lysine bound SMO DHDPS indicates a non-globular rod-like 
structure (Figure 3.8). In a globular structure, the distribution would follow a standard 
bell curve as the distribution of mass is spread evenly around the centre of the protein. 
However, this data shows a noticeable skew off to the left with an uneven distribution. 
This indicates that the protein is not globular in solution and may represent a rod-like 
dimeric structure. 
 
The proteins scatter data can also be compared with the A. thaliana and E. coli native 
tetrameric crystal forms and two hypothetical dimeric crystal forms; each representing 
a different possible dimer (Figure 3.9 and Table 3.1). The lysine bound form much 
more strongly fits the two dimeric forms (0.58,0.59) rather than the bacterial or plant 
type tetrameric form (1.60, 1.35). This also indicates that the lysine bound form is 
likely to be a dimeric species. 
 
However, this does not indicate which dimer is being formed. It could be speculated 
that the interdimeric species is the one that forms. Lysine binding may cause 
dissociation of the lysine binding site interface. However, the greater surface area of 
this interface compared to the interdimer interface could mean that the interface is 
more resilient to movement in residues. The interdimeric interface has much less 
surface area and may be more susceptible to residue movement which could cause 
dimeric dissociation. The Chi2 fits do not show a statistically significant difference 




auerus exist in the intradimeric formation. Further investigation as to the dimeric 
nature of the enzyme is of interest to see if it is in an identical dimeric configuration 
to the native DHDPS enzymes or in a novel interdimeric configuration. If the dimeric 











Figure 3.9: The two possible dimeric forms of SMO DHDPS based on the structure of 






Figure 3.10: Intensity plot (log I vs S) (a) and distance distribution plot (P (R)) (b) for 
SMO DHDPS in presence of 5 mM pyruvate. 
  




E. coli DHDPS 23.30 




The P(R) plot of pyruvate bound DHDPR indicates a globular structure (Figure 3.10). 






bound curve, the protein exists in a much more globular tetrameric shape than its 
lysine bound equivalent. The Chi2 fits also indicate a tetrameric structure (Table 3.2). 
The fit for the tetrameric plant type species from A. thaliana is much stronger (1.54) 
then either the bacterial form tetramer from E. coli (23.30) or the two dimeric species 
(17.22, 17.23). Both of these factors are strong evidence for the pyruvate bound form 
of SMO DHDPS existing in a plant type tetrameric arrangement. 
 
Table 3.3: SAXS parameters for SMO DHDPS in two different buffers along with A. 
thaliana. 
Organism Ligand Rg (Å) Io Porod 
Volume (Å3) 
A. thaliana No Ligand 36.4±0.2 0.055 271,021 
S. moellendorffii  5 mM Lysine 31.5±0.3 0.019 127,080 
S. moellendorffii  5 mM Pyruvate 38.6±1.9 0.03 285,373 
 
These dimeric and tetrameric observations are backed up by the radius of gyration and 
zero angle intensity (Io) (Table 3.3). The radius of gyration is an indicator of the 
distribution of mass around the centre of a protein. This gives an indication of the 
diameter and size of the protein. The zero-angle intensity gives an indication of the 
intensity of radiation scattered through zero-angle. The radius of gyration for the 
pyruvate bound form is similar to the A. thaliana radius. However, when both A. 
thaliana and the pyruvate bound scatter patterns are compared to the lysine bound 
SMO DHDPS, the radius of gyration for this protein is markedly lower than the 
tetrameric forms. Porod volumes express an estimated molecular weight of 1.6x that 
of the actual weight. Taking this into account, it also shows that the lysine bound form 
(~79,000 Da) has a volume approximately half that of the pyruvate bound structure 
(~178,000 Da). These factors reinforce the idea that the quaternary structure of SMO 











Figure 3.11: GASBOR model created from SMO DHDPS in the presence of 2 mM 





Figure 3.12: GASBOR model created from Selaginella moellendorffii in the presence 





In order to gain an insight into the 3D structure; a low resolution ab initio model was 
created using the program GASBOR (Svergun et al., 2001). The model created using 
the lysine bound data more closely resembled the dimer than the tetramer (Figure 
3.11). This was in contrast to the pyruvate bound model which much more closely 
resembled a plant type tetramer (Figure 3.12).  
 
While SAXS is a powerful technique in the determination and comparison of single 
species solutions, it has limitations when more than one species is present in solution. 
This makes it unsuitable to find information about the species with no ligand present. 
It also does not have a high enough resolution to determine exactly which dimer is 
formed. 
 
3.6  X-ray Crystallography 
 
To generate a 3D high resolution structure, the protein was screened using JCSG+ and 
PACT crystal screens due to their high success rate in DHDPS-like proteins in the 
past. If successful, a high-resolution 3D structure of the protein could be formed. 
Initially, crystallisation was attempted using a method that led to crystal formation in 
other DHDPS and DHDPS-like proteins. Two separate trials were done, one with 5 
mM lysine and the other 5 mM pyruvate. Both ligands force the equilibrium into a 
single species which should allow for a higher chance of crystallisation. However, 
these attempts were unsuccessful. The next attempt increased the ligand 
concentrations from 5 to 10 mM to increase to stability and homogeneity of the 
protein. The protein concentration was also greatly lowered to ~2.5 mg/ml in an 
attempt to replicate a previous successful attempt to crystallise Vitis vinifera 
(grapevine) DHDPS (Atkinson et al., 2011).  However, this also proved unsuccessful. 
In a final attempt to generate crystals, a tray using the same crystallisation conditions 
but a vastly increased protein concentration (~28 mg/ml) was created. This attempt 
was also unsuccessful. Successful crystallisation of the protein is an avenue of further 
investigation into the exact position of its dimer interface residues and may indicate 





There are many other parameters that could have been changed to allow for protein 
crystallisation. For example, alternate screens such as Morpheus and Midas would 
include conditions that were not present on JCSG+ and PACT. However, JCSG+ and 
PACT contain a large variety of conditions that have previously been used to 
crystallise other DHDPS so it is likely that these screens had the highest likelihood of 
crystallisation. 
 
The sitting drop method was used in these experiments however the vapour diffusion 
is an alternate method that could be initiated. This technique involves vapour from a 
precipitant well diffusing into a protein well in a sealed environment. Another form of 
crystallisation is the hanging drop method. This technique involves a drop of protein 
solution hanging slightly above a precipitant solution in a sealed environment. This is 
the technique used in many examples of DHDPS crystallisation and may be more 
conducive to protein crystallisation (Dobson et al., 2005a, Griffin et al., 2008, Pearce 
et al., 2008). It is also possible that variation in temperature could increase the 
probability of crystallisation. Other examples of DHDPS crystallisation use a 
variation of temperatures ranging from 4-12 °C. Therefore, there remains a number of 
parameters that remain to be tested in order to optimise protein crystallisation.   
 
3.7  Differential Scanning Fluorimetry  
 
In order to determine protein stability of dimeric and tetrameric species and the 
influence of ligand binding, melting temperatures were determined by Differential 
scanning fluorimetry (DSF). This is a technique that measures the unfolding of a 
protein with increasing temperature using a hydrophobic fluorescent dye that binds 
the protein as it unfolds. Using this data, the melting point of SMO DHDPS under 






Figure 3.13: DSF data for conditions of no ligand and two concentrations of lysine. 
 
 
Figure 3.14: DSF data for conditions of no ligand and two concentrations of pyruvate. 
 
 
Figure 3.15: DSF data for conditions of no ligand and two concentrations of both 








Table 3.4: Melting temperatures for SMO DHDPS under various ligands 
Ligand Condition Tmave 
(°C) 
No Ligand 47.9±0.1 
2 mM Lysine 55.5±0.1 
10 mM Lysine 63.8±0.2 
2 mM Pyruvate 52.9±0.3 
10 mM Pyruvate 55.4±0.1 
2 mM Lysine + 2 mM Pyruvate 66.0±0.1 
10 mM Lysine + 10 mM Pyruvate 66.7±0.2 
 
From these melt curves, the temperature stability of the DHDPR enzymes can be 
found (Table 3.4). In absence of ligand, the enzyme has a Tm of 47.9 ºC (Figure 3.13). 
This is considerably lower than other measured Tms from other DHDPS enzymes 
such as B. anthracis and E. coli (59.8 ºC and 61.3 ºC) (Burgess et al., 2008). In other 
DHDPS, pyruvate has been found to stabilise the enzyme (Kefala et al., 2008, 
Domigan et al., 2009, Burgess et al., 2008). SMO DHDPS is no different with a 5.1 
ºC increase upon addition of 2 mM pyruvate and a 7.6 ºC increase when 10 mM 
pyruvate is added (Figure 3.13). Interestingly, a greater stability increase is also 
observed in the presence of lysine (Figure 3.14). A 7.6 ºC increase in stability is 
observed in 2 mM lysine and a 15.9 ºC increase with 10 mM lysine present. An 
increase in stability is also observed in the presence of both ligands with 18.6 °C and 
18.8 °C increases at 2 and 10 mM concentrations of both lysine and pyruvate (Figure 
3.15). As the equivalent amount of lysine stabilises the protein more than the 
equivalent amount of pyruvate, it seems that binding of ligand at the lysine binding 
site increases thermal stability to a higher extend than the substrate binding site. 
 
3.8  Conclusions 
 
3.8.1  Proposed Evolutionary Pathway 
With discovery of the dimer-tetramer equilibrium of SMO DHDPS, an expanded 
evolutionary pathway can be proposed. A dimeric DHDPS from S. auerus or P. 




organism. A substrate mediated equilibrium similar to SMO DHDPS where pyruvate 
shifts the equilibrium towards the tetrameric form has been observed in B. anthracis 
(Voss et al., 2010). This equilibrium could be considered an intermediate between the 
bacterial tetrameric arrangement and dimeric DHDPS. With the discovery of the SMO 
DHDPS equilibrium, this allows an equivalent pathway for the formation of the plant 
type DHDPS from the ancestral dimer. This makes the discovery of SMO DHDPS an 
important “missing link” in the evolution of the enzyme (Figure 3.16).  
 
Figure 3.16: The two possible evolutionary pathways of DHDPS. The bacterial 
DHDPS could possibly have evolved into the dimeric form and towards the plant 
form (black). It is also possible that both the bacterial and plant tetramers both 
evolved from the dimeric ancestor (blue). Shown on the diagram: S aureus, B. 
anthracis, E. coli, S. moellendorffii (GASBOR) model and A. thaliana. 
 
While each stage of the proposed evolutionary pathway has been found, the exact 
method that the pathway has formed is unknown. It could occur in two different ways. 
One possible pathway involves a split from the dimeric form to generate the bacterial 




bacterial tetrameric form evolved back into the dimeric from which then evolved into 
the tetrameric form. 
 
This proposed evolutionary mechanism could have possible implications in the 
evolution of other DAP pathway enzymes and other enzymes. For example, it is 
possible that a similar evolutionary mechanism exists in DHDPR which will be 
explored later in the DHDPR sections. The model may also be able to be applied to 
the evolution of other enzymes in the future.  
 
3.8.2  Summary 
SMO DHDPS exists in a substrate-dependent equilibrium between dimer and tetramer. 
AUC and SAXS show that in the presence of the allosteric inhibitor lysine, the protein 
exists in a dimeric conformation. However, the presence of pyruvate shifts the 
quaternary structure into a tetrameric conformation similar to the native plant type 
tetrameric structure. With no ligand present, AUC shows that the protein exists in a 
dimer-tetramer equilibrium. DSF shows that while both pyruvate and lysine binding 
increase the stability of the protein, lysine stabilises it by a higher amount. The 
observation of this equilibrium can be seen as an evolutionary “divergence point” in 



















Chapter 4 – Algal DHDPR Enzymes 
 
4.1  Background 
 
4.1.1  Quaternary Structure 
DHDPR catalyses the second committed step in the DAP pathway. As the second 
committed step in the DAP pathway, the enzyme remains relatively unstudied 
compared the first committed step catalysed by DHDPS. The (4S)-hydroxy-2,3,4,5-
tetrahydro-(2S)-dipicolinic acid (HPTA) formed from the DHDPS step is converted to 
L-2,3,4,5-tetrahydrodipicolinate (THDP) using an NADH or NADPH cofactor. The 
enzyme was first isolated and purified in 1973 by Hadassah Tamir and Charles 
Gilvarg (Tamir and Gilvarg, 1974). Its monomeric arrangement, like DHDPS, exists 
as a repeating subunit in a dimeric or a tetrameric arrangement, depending on the 
organism type (Pearce et al., 2008, Reddy et al., 1995). In all bacterial DHDPR 
characterised so far, the protein exists as a homo-tetramer. However, plant type 
DHDPR enzymes characterised so far have been found to exist as homo-dimers 
(Griffin et al., 2012, Watkin, 2014).  
 
Figure 4.1: E. coli DHDPS in its tetrameric structure with the nucleotide binding 
domain shown in red and the binding loop shown in green. The substrate binding 




The general structure of a DHDPR subunit in E. coli consists of two distinct domains; 
the C- and N-terminus domains (Figure 4.1). Each domain has a different structure 
and function (Scapin et al., 1995). The C-terminus domain consists of four β-sheets 
and two α-helices which are arranged on the bottom of the β-sheets. This domain is 
involved in substrate binding as well as maintaining quaternary structure of the 
protein. The N-terminus domain consists of seven β-sheets and four α-helices 
arranged in a Rossmann fold; a fold common among other nucleotide binding proteins 
such as Lactate Dehydrogenase and Ferrodoxin. 
 
4.1.2  Mechanism 
The reaction proceeds via a ordered sequential ping pong reaction order in which the 
nucleotide cofactor binds first, followed by HTPA, with the product THPA leaving 
first after the reaction followed by the reduced nucleotide cofactor (Figure 4.2) 
(Reddy et al., 1995) (Scapin et al., 1997). It is characterised by rapid hydride transfer 
followed by a slower rate-determining step to stabilise the nitrogen ring and complete 
the reaction.  
 
Figure 4.2: The proposed mechanism for DHDPR (adapted from (Scapin et al., 1997)) 
 
In the proposed reaction mechanism, Lys 163 and His 159 are thought to be critical to 
the reaction chemistry. Mutation of these residues to alanine and glutamic acid – 
residues that did not contain any charged side chains markedly reduced substrate 
affinity and almost eliminated the reaction rate to zero (Scapin et al., 1997).  As an 
unexpected feature of the mechanism, the protein exhibits dehydratase activity to 
convert HTPA to DHDP (Devenish et al., 2010). It was initially thought that DHDPR 
used DHDP as its substrate and that the dehydration of HTPA occurred spontaneously 
in solution. The discovery that an increased rate of DHDP formation is linked with 
DHDPR concentration shows that DHDPR directly accepts HTPA as a substrate. This 
is hypothesised to occur with His 159 acting as a base, deprotonating HTPA to form 
DHDP (Devenish et al., 2010). However, the exact mechanism of this step in the 





Specificity is another important aspect of DHDPR substrate binding. Several (S)-ASA 
substrate analogues were found to be turned over in DHDPS (Devenish et al., 2010). 
However, the resulting product was found to not be compatible with DHDPR. This 
shows that DHDPR has a different element of substrate specificity than DHDPS. 
 
4.1.3  Domain Dynamics  
Domain dynamics are also critically important in the mechanism. Binding of the 
substrate is thought to rely on a conformational change between the two domains 
(Figure 4.3) (Janowski et al., 2010). One proposed mechanism states that the protein 
exists in the “open” conformer with no ligands bound. Nucleotide binding is thought 
to shift the protein into an equilibrium between open and closed forms with HTPA 
binding forcing the monomer into the “closed” conformation. 
 
 
Figure 4.3: The proposed binding mechanism of DHDPR substrate binding. 
 
The conformational change is centred around a “hinge region” consisting of two loops 
containing residues Phe 129 – Ser 130 and Ser 239 – Arg 240 in E. coli (Figure 4.4). 
Upon overlay of no ligand bound and PDC/NADH bound crystal forms, a 16° rotation 
around the hinge region is observed (Scapin et al., 1997). Similar domain movement 
has also been observed in S. aureus DHDPR with a rotation angle of 11° between two 






Figure 4.4: This is an overlay of the ligand unbound (cyan) and PDC-NADH bound 
(green) E. coli DHDPR. 
 
This conformational change is thought to occur in three parts. HTPA binds first to the 
enzyme. This was found induce a greater conformational change than the other steps 
(Ge et al., 2008). The next two steps are both NADH binding events. One monomer 
was found to bind NADH before the others resulting in negative cooperativity. This 
was followed by a 2nd binding event of either two or three NADH molecules binding 
at once. While crystal structures containing NADH typically contain three of their 
active sites filled with nucleotide and one that remains unbound, it is unclear whether 
this is representative of the actual binding mechanism or an artefact of crystal packing. 
Exactly how this cooperativity occurs is also uncertain. It is speculated that a change 
in the position of Arg 16 is initiated by Glu 51 movement upon NADH binding, 
which causes a small rearrangement leading to increased inter monomer repulsion 
with more than one NADH bound (Ge et al., 2008). 
 
4.1.4  Nucleotide Binding Loop 
In binding of the nucleotide cofactor, a conserved region consisting of GXXGXXG in 
most DHDPR enzymes has been observed in E. coli, M. tuberculosis, T. maritima and 




1995, Janowski et al., 2010, Pearce et al., 2008). As a protein that can utilise both 
NADH and NADPH, M. tuberculosis DHDPR is an important model in nucleotide 
binding. In this case, lysine residues 9 and 11 have been found to anchor NADPH to 
the protein (Cirilli et al., 2003). Mutations of these residues greatly decreased 
NADPH affinity. 
 
Figure 4.5: The nucleotide binding loop consisting of residues Gly 12 to Gly 18 
(shown in cyan) binding to NADH (green) along with other residues deemed 
important (Glu 38, His 39, Gly 84 and His 88) (yellow) in nucleotide binding. 
 
However, these residues are not conserved in other DHDPR enzymes, even in those 
that bind NADPH, indicating that the binding residues may differ slightly between 
individual DHDPR enzymes. While most characterised and uncharacterised DHDPR 
enzymes discovered so far contain the critical glycine residues in the nucleotide 
binding motif, some organisms such as S. auerus have small variations such as an 
asparagine in place of the third glycine with similar nucleotide affinity (Dommaraju et 
al., 2011). This may mean that the exact nature of the residues nucleotide binding 





The nucleotide binding motif along with two specific upstream residues have been 
speculated to dictate whether the enzyme expresses a preference towards NADH, 
NADPH or both nucleotides (Dommaraju et al., 2011). In E. coli, an aspartic or 
glutamic acid located 19-20 residues upstream from the GXXGXXG at position 38 
was found to hydrogen bond with two hydroxyls in the ribose moiety of NADH 
(Scapin et al., 1995). The phosphate group of NADPH was also found to interact with 
the basic Arg 39. These residues were hypothesised to decide if the protein prefers to 
utilise NADH or NADPH. However, there are exceptions to this. For example, S. 
auerus DHDPR exhibits substrate affinity and rate while utilising NADPH but lacks a 
basic residue equivalent to Arg 39 (Dommaraju et al., 2011). It is also thought that N 
terminus rearrangement allows Lys 35 interaction with the phosphate of NADPH, 
accounting for its nucleotide specificity (Girish et al., 2011). NADPH binding was 
reduced 20-fold in a K35A mutant which reduced side chain functionality. It is 
therefore uncertain exactly which residues are responsible for nucleotide specificity 
due to inconsistencies in proposed binding hypotheses. 
 
4.1.5  Substrate Binding Loop 
The substrate binding loop is a critically important region of the protein in terms of its 
function. This is marked by a short binding loop region between Glu 157 and Ala 171 
(in E. coli) (Scapin et al., 1995). These residues along with residues Gly 102 – Phe 
106 and Ala 126 – Ser 130 from the other domain form a substrate binding pocket. 
Residues in this pocket hydrogen bond with the substrate allowing the residues 






Figure 4.6: This image shows the substrate binding region (shown in cyan) in addition 




















4.1.6  Dimer Interfaces 
The dimer interfaces of the protein are also important in stabilising the dynamics of 
the protein. One dimer interface is characterised by four-stranded β-sheets from each 
monomer, hydrogen bonding to form an eight-stranded mixed β-sheet (Figure 4.7). 
This pairs face to face with the other dimer interface in tetrameric species, forming a 
16-strand mixed β-barrel. This structure is anchored by the other dimer interface loops 
and the outermost β-strand. 
 
Figure 4.7: The β-sheet dimer interface. Residues 229-238 from each dimer are shown 







The other dimer interface is created by two loops, Glu 195 – Pro 203 from one 
monomer and Val 164’ and Pro 167’ from another (Figure 4.8). These two loops form 
hydrogen bonding interactions which anchors the two subunits together. These two 
dimer interfaces combine to form a tetrameric structure.  
 
Figure 4.8: The loop binding interface and the two loops that form this interface: Glu 





4.2  Evolutionary Divergence  
 
4.2.1  Quaternary Structural Differences 
DHDPR, like DHDPS, also exhibits quaternary structural differences between plant 
and bacterial proteins. All bacterial species characterised so far have been found to 
exist as tetramers (Cirilli et al., 2003, Girish et al., 2011, Janowski et al., 2010, Scapin 
et al., 1995). While characterisation of plant DHDPRs so far remains limited, A. 
thaliana and Vitis vinifera DHDPR have both been found to exist as dimers (Griffin et 
al., 2012, Watkin, 2014). This difference in quaternary structure is due to an 
evolutionary divergence at some point that made it favourable to switch to a dimeric 
structure but it is unknown exactly how or where this occurred. 
 
4.2.2  Nucleotide Utilisation  
DHDPR enzymes have varying affinities for nucleotide co-factors. Some bacterial 
DHDPR enzymes such as those from E. coli and M. tuberculosis have dual specificity 
for both NADH and NADPH (Cirilli et al., 2003, Reddy et al., 1996). Other bacterial 
DHDPR express a strong preference towards NADPH, such as that from S. aureus 
and T. maritima (Girish et al., 2011, Pearce et al., 2008). A. thaliana DHDPR has 
been shown to utilise NADPH, possibly due its association with the light reactions in 
plants (Griffin et al., 2012). These nucleotide associations may be linked to 
evolutionary advantages depending on the organism’s environment.   
 
Substrate inhibition occurs in many DHDPR enzymes. While most express a higher 
affinity to a specific nucleotide, high concentrations of substrate can lead to substrate 
inhibition whilst utilising that nucleotide. This effect has been observed in S. auerus 
and T. maritima among others (Dommaraju et al., 2011, Pearce et al., 2008). In both 
cases, high concentrations of substrate led to greatly increased levels of inhibition 
compared to the other nucleotide. However, the concentration required for this 
inhibition was not thought to be physiologically relevant. Substrate inhibition is 
thought to result from HTPA binding to the enzyme before the oxidised nucleotide 





It has also been speculated that some forms of the enzyme can be inhibited by lysine 
(Tsujimoto et al., 2006). A DHDPR from Methylophilus methylotrophus was found to 
be inhibited by lysine with inhibition increasing along with lysine concentration. 
However, this effect has not been observed in any other DHDPR characterised so far 
making it uncertain whether this effect is observed in other DHDPR enzymes or is 
exclusive to this group of organisms. 
 
DHDPR substrate inhibition is an aspect of the DAP pathway that is commonly 
ignored in the creation of higher lysine DAP pathways. With the many attempts that 
have been made at higher lysine organisms in bacteria and plants, most of these have 
neglected to take account of feedback inhibition when utilising a specific nucleotide. 
In bacteria that can utilise both nucleotides without a loss in rate or substrate affinity, 
this would not be a great deal. However, in bacteria, plants and algae that exhibit 
nucleotide induced substrate inhibition, increased levels of substrate may not 
necessarily lead to increased product. It is therefore important to ensure that the 
correct nucleotide is being used when the pathway is being manipulated to increase 
lysine production. 
 
4.3  Phylogenetic Analysis 
 
As DHDPR exists in two separate quaternary conformations in bacteria and plants, its 
evolution is of great interest in algal species. Phylogenetic analysis of DHDPR 






Figure 4.9: This is a phylogenetic tree created using www.phylogeny.fr 
 
 Figure 4.10: Another phylogenetic tree; created using www.ebi.ac.uk 
 
Interestingly the two trees have significant differences (Figures 4.9 and 4.10). These 
two phylogenetic trees use slightly different sorting methods. This explains the slight 
differences between trees. In both instances, the bacterial and plant species are 
grouped together as expected. B. subtillis, P. aeruginosa and E. coli remain grouped 
together in both trees. Lycophytic and plant enzymes from A. thaliana, O. sativa and 
S. moellendorffii remain bunched together in a separate portion of the tree, showing 
that they are likely to have similar properties. Red algal species G. sulphuraria and C. 
merolae along with the brown algal species E. siliculosus remain bunched very close 
to each other in both trees. All of these species remain above plants in the tree making 
their quaternary structure uncertain between plant and bacterial formations. 
Characterisation of these proteins will allow the evolutionary nature of each of these 





Green algal species placement varies depending on the tree. In the phylogeny.fr tree, 
O. tauri and C. subellipsoidea exist after plant species but in the ebi.ac.uk tree, they 
exist before plants. Due to their close grouping to plants in either case, it can be 
hypothesised that they will retain similar characteristics to plant type DHDPR 
enzymes.  What’s more interesting, however, is the placement of the green algal C. 
reinhardtii DHDPR. In the phylogeny.fr tree, it is placed on its own; right after the 
bacterial species and before the algal species. In contrary to this, the ebi.ac.uk tree 
places the protein squarely amongst the bacterial species.  The exact location of its 
placement is unknown but this discovery suggests that the C. reinhardtii DHDPR 






















4.4  Sequence Alignment 
 
To gain more information about specific residues of each protein, a multiple sequence 
alignment (MUSCLE) containing each amino acid sequence was created using Clustal 













Figure 4.11: Sequence alignment for Chlamydomonas reinhardtii, Galdieria 
sulphuraria, Ectocarpus siliculosus, Cyanidioschyzon merolae, Coccomyxa 
subellipsoidea, Ostreococcus tauri, Ostreococcus lucimarinus, Arabidopsis thaliana, 
Selaginella moellendorffii, Oryza sativa, Bacillus subtilis, Escherichia coli and 
Pseudomonas aeruginosa. 
  
Two regions in the protein are of particular importance. The GXXGXXG nucleotide 
binding motif is critical to NAD(P)H binding and is conserved among other 
nucleotide binding proteins such as Lactate Dehydrogenase and Ferrodoxin. While the 
motif is conserved in A. thaliana, E. coli E. siliculosus and O. tauri, in other algal and 
lycophyte protein sequences the motif is disrupted (Figure 4.11). 
 
The first glycine residue is replaced by an aspartic acid in S. moellendorffii. This first 
glycine is highly conserved among DHDPR enzymes making it important in 
nucleotide binding. However, in E. coli, this residue does not make as many direct 




it can be replaced by another residue such as an aspartic acid which may play a 
similar role. 
 
The second glycine in the motif is completely conserved in every DHDPR analysed. 
This indicates that the residue is critically important in nucleotide binding and its 
positioning is highly specific; it hydrogen bonds to a hydroxyl on the ribose ring of 
NADH as well as an oxygen on the phosphate backbone of the nucleotide. It is likely 
that this residue plays a significant role in binding nucleotide to the protein in a 
position that NADH can donate its proton. 
 
In the two red algal species characterised, the third glycine residue is replaced with 
another residue; in G. sulphuraria it is swapped out for a serine, whereas in C. 
merolae, it is replaced with an alanine. Like the first glycine residue, this does not 
make as much contact with the NADH molecule as the critical second glycine residue. 
This may mean that the serine and alanine replacements can fulfil a similar role to the 
glycine in nucleotide binding. 
 
The substrate binding loop containing residues Glu 157 to Ala 171 is another 
sequence of interest. In all DHDPR enzymes characterised thus far, two residues (His 
159 and Lys 163) are thought to be critical to the mechanism. While they are present 
in all other sequences analysed, they are not present in C. reinhardtii. This contrasts 
with the proposed mechanism which uses a Schiff base formed by lysine that 
stabilises the substrate along with a histidine electron acceptor. However, in C. 
reinhardtii these residues are replaced with an alanine and glycine respectively. These 
residues do not contain the side chain functionality that their counterparts do so C. 
reinhardtii must utilise alternative residues with a similar function, or a different 
mechanism. It is also interesting to note that the rest of the binding region only retains 
2 of the 15 other residues from the E. coli substrate loop and contains an additional 
residue. These two retained residues are not thought to directly contribute to substrate 
binding but may function in stabilisation of the substrate. 
 
Another thing that is interesting to note about the C. reinhardtii DHDPR sequence is 
the presence of an extra cysteine residue. It is possible that this extra residue may play 




this interface are unknown. This extra residue matches with E. coli DHDPR in a 
region that looks unlikely to form a disulfide bond. This may mean that in C. 
reinhardtii DHDPR, the residue is orientated in a position that could allow a disulfide 
interface to occur. It is also possible that the other conserved cysteine residues are 
orientated in positions that allow a disulfide bond to occur. The properties of this 
enzyme are explored further in the C. reinhardtii DHDPR chapter. 
 
4.5  Enzyme Kinetics 
 
To test the kinetics of each DHDPR enzyme, enzyme activity assays were performed. 
This gave an insight into the nucleotide utilisation of each enzyme as well as substrate 
affinity and inhibition (Table 4.1).  
 
Table 4.1: The kinetic parameters for each organism while utilising each nucleotide. 
Organism Nucleotide Km (mM) Vrel (μmol/mg/s) Vrel/Km Ki (mM) 
E. coli NADH 0.32±0.055 0.0047±0.00036 0.015  
E. coli NADPH 0.29±0.00010 0.0079±0.00010 0.027  
A. thaliana NADH 0.73±0.16 0.0046±0.00067 0.0063 2.20±0.60 
A. thaliana NADPH 0.62±0.088 0.0011±5.414x10-5 0.0018  
T. maritima NADH 8.67x10-14±0.014 0.00023±0.00090 2.62 0.93±0.34 
T. maritima NADPH 0.051±0.0055 0.028±2.743x10-5 0.56 24.60±14.30 
E. siliculosus NADH 0.099±0.021 8.433x10-5±8.317x10-6 0.00085 1.23±0.28 
E. siliculosus NADPH 0.11±0.0087 6.932 x10-5±2.253x10-6 0.00061 3.67±0.44 
C. subellipsoidea NADH 0.81±0.15 0.017±0.0014 0.022  
C. subellipsoidea NADPH 0.87±0.15 0.017±0.0011 0.017  
O.tauri NADH 0.14±0.024 0.001869±0.00014 0.013 7.34±3.02 
O.tauri NADPH 0.39±0.053 0.0013±4.943x10-5 0.0032  









Figure 4.12: Kinetics for E. coli DHDPR. The data was fitted to a standard Michalis-
Menten kinetic profile. 
 
Figure 4.13: The kinetics for A. thaliana DHDPR. The NADPH data was fitted to a 
standard Michalis-Menten kinetic profile whereas the NADH data was fitted to a 







Figure 4.14: The kinetics for T. maritima. Both curves were fitted using a substrate 
inhibition model. 
 
Three enzymes were used as controls, the first of which was E. coli DHDPR (Figure 
4.12). This typically has a greater affinity for NADPH but can utilise both nucleotides 
(Coulter et al., 1999). In this case, the Km values are similar but the Vrel is higher 
when NADPH is utilised. This kinetic profile will be used as one of the models for 
kinetics for a bacterial DHDPR. 
 
The other bacterial model that will be used is T. maritima DHDPR (Figure 4.13). This 
uses a different model of nucleotide utilisation which expresses a much stronger 
substrate affinity and rate whilst utilising NADPH (Pearce et al., 2008). With NADH, 
it exhibits extremely strong substrate inhibition and a rate many times lower than that 
with its phosphorylated counterpart. 
 
A. thaliana DHDPR has a noticeably different kinetic profile than the two bacterial 
models (Figure 4.14). It expresses a similar affinity for both NADH and NADPH 
(Griffin et al., 2012). However, it expresses a higher rate along with substrate 
inhibition while utilising NADH. As the reaction takes place in the chloroplast, it is 








Figure 4.15: The kinetics for C. merolae DHDPR. Both curves were fitted using a 
substrate inhibition model. 
     
 
Figure 4.16: The kinetics for E. siliculosus DHDPR. Both curves were fitted using a 
substrate inhibition model. 
 
Both red and brown algal species characterised have similar kinetic profiles. The red 
algal DHDPR from C. merolae may be able to utilise both substrates in vivo. It has a 
much higher affinity for NADPH; however, it has a greater maximum rate whilst 
utilising NADH (Figure 4.15). In each case, a novel substrate utilisation profile is 
observed, with severe substrate inhibition observed while utilising both nucleotide 
substrates. However, this may not usually be the case due to the stability of the 
enzyme. The enzyme was unstable over long periods of time and the substrate 
inhibition may have been caused by protein degradation causing formation of the 




that as red algae contain chloroplasts, they utilise NADPH due to the enzymes 
location in the chloroplast where NADPH is ubiquitous due to its role in the light 
reactions. The brown algal DHDPR from E. siliculosus exhibits a similar kinetic 
profile to that of C. merolae (Figure 4.16). While its substrate affinity appears similar 
between both nucleotides, it exhibits a slightly higher rate whilst using NADH rather 
than NADPH. Substrate inhibition is observed in both cases but is more pronounced 
in NADH. This reinforces the idea proposed by the evolutionary lineage that the 
brown algal species are closely related to their red algal counterparts. 
 
 
Figure 4.17: The kinetics for C. subellipsoidea DHDPR. Both data sets were fitted to 
a standard Michalis-Menten kinetic profile. 
 
 
Figure 4.18: The kinetics for O. tauri DHDPR.  The NADPH data was fitted to a 
standard Michalis-Menten kinetic profile whereas the NADH data was fitted to a 






Figure 4.19: The kinetics for O. lucimarinus DHDPR. The NADPH data was fitted to 
a standard Michalis-Menten kinetic profile whereas the NADH data was fitted to a 
substrate inhibition model. Data for NADPH is not shown as the protein was 
unreactive when this nucleotide was used. 
 
As for the green algal species, C. subellipsoidea shows a similar kinetic profile to E. 
coli DHDPR (Figure 4.17). This is characterised by a complete lack of substrate 
inhibition and an extremely similar affinity towards both nucleotides. This contrasts 
with O. tauri DHDPR which exhibits a much stronger affinity and higher rate whilst 
utilising NADH rather than NADPH (Figure 4.18). However, substrate inhibition is 
much more prevalent whilst utilising NADH. This kinetic profile is similar to A. 
thaliana DHDPR. 
 
O. lucimarinus has another unique kinetic profile. This utilises NADH with an 
extremely tight affinity with minimal substrate inhibition (Figure 4.19). However, 
when NADPH was utilised, no increase from a minimal level of activity was observed. 
This profile appears to be similar to T. maritima except with a reversed nucleotide 
utilisation with NADH being the main nucleotide. The O. lucimarinus DHDPR 
protein sequence contains all of the catalytic residues responsible for catalytic activity 
so it is uncertain exactly why it does not utilise NADPH. However, it is possible that 
the sample was contaminated with Lactate Dehydrogenase. Lactate Dehydrogenase 
catalyses a reaction between pyruvate to lactate and back again using specifically 




the sample which would explain the lack of observed activity when NADPH was used 
as the nucleotide co-factor. It is also possible that the protein concentration was not 
sufficient to observe enzyme activity. High levels of substrate inhibition may have 
meant that an observable rate was simply not possible at the enzyme assay 
concentration. 
 
The exact kinetic parameters for these enzymes is difficult to characterise for many of 
the algal DHDPR proteins. For example, many of them are extremely unstable and 
lose measurable activity very quickly. Due to this fact, it can be challenging to find an 
accurate maximum rate of the enzyme. This means that the rates between enzymes 
cannot readily be compared. 
 
Another reason the rates cannot be trusted between enzymes is an issue with 
calculation of the concentration of the protein. For all calculations of protein 
concentration, a Nanodrop was used. This is a device that measures light absorbance 
at 280 nm; the wavelength at which the peptide bond absorbs. However, a much 
larger peak at 260 nm was observed which renders the peak at 280 nm distorted. 
Variables that can modify absorption at 260 nm include DNA, nucleotides and 
changes in acidity. As this protein binds nucleotides as part of its mechanism, it is 
likely that this contamination is the caused by binding of nucleotide during 
purification. 
 
The contamination meant that while the Vrel’s within the same protein sample can be 
compared, interspecies comparison of rates may not necessarily be possible. This 
would not affect the Km however, which is independent of protein concentration. This 
certainly can be compared between species and is an important tool in characterisation 
of the algal DHDPR’s.  
 
4.6  Quantitative Size Exclusion Chromatography  
  
To analyse the molecular weights of each protein, quantitative size exclusion 
chromatography was used. This involved loading a set volume of protein onto a size 




protein weights can be estimated to determine whether they are in a tetrameric or 
dimeric state (Table 4.2).   
 
Table 4.2: DHDPR elution time on a size exclusion column. 






T. maritima Bacteria 10.12 94,424 Tetramer 
A. thaliana Plant 14.03 75,740 Dimer 
C. subellipsoidea Green Algae 14.07 58,750 Dimer 
O. lucimarinus Green Algae 17.79 64,602 Monomer 
O. tauri Green Algae 13.25 59,884 Dimer 
C. reinhardtii Green Algae 10.91/12.50 133,716/66,858 Tetramer/Dimer 
C. merolae Red Algae 13.51 68,094 Dimer 
G. sulphuraria Red Algae 13.49 62,552 Dimer 
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Figure 4.20: A sample SEC UV trace from the experiment. The two major peaks that 
exhibited activity are shown; at 10.97 ml peak with a height of 550 mAU residing on 





To be used as controls, tetrameric T. maritima and dimeric A. thaliana DHDPR 
enzymes were the first to be characterised using the column. This allows the 
remaining DHDPR enzymes to be compared to these benchmarks. Two of the green 
algal DHDPR enzymes were found to elute at a similar volume to the plant DHDPR 
enzymes. This is evidence that they may exist in a dimeric conformation. The other 
green algal DHDPR from C. reinhardtii had two peaks that exhibited activity 
corresponding to dimer and tetramer (Figure 4.20). The red algal species were found 
to exist at very similar elution volumes to the plant type dimer indicating that they 
may exist in a dimeric conformation. The brown algal species E. siliculosus also 
elutes at a similar volume to other dimers, indicating that it also exists as a dimer.  
 
The results indicate that almost all the algal species characterised appear to exist in a 
dimeric formation. This corresponds to the proposed evolutionary lineage in which 
the algal species tested apart from C. reinhardtii are hypothesised to exist in a dimeric 
conformation. The exception was the green algal DHDPR from O. lucimarinus. As 
this enzyme was unstable during purification and kinetic assays, it is possible that the 
enzyme lost its quaternary structure and exists in a monomeric form. This form could 
still be catalytically active albeit at a much lower rate which was observed in the 
kinetic assays. 
 
The reason that this technique was used instead of more accurate techniques such as 
AUC or size exclusion chromatography – multi angle light scattering (SEC-MALS) is 
that many of these proteins do not have sufficient stability or purity to be analysed 
using these techniques. AUC requires a sample purity of 95% which is not necessarily 
possible to achieve with some of these algal proteins despite a two-step His Tag and 
size exclusion chromatography column purification. This technique was used over 
SEC-MALS due to the sensitivity of the technique to aggregates and contaminants. 
As both are prevalent in these algal species, an upscaled version of the technique was 
used to characterise the proteins. This technique required more labour than a 
traditional SEC-MALS experiment but due to the lower resolution of the column, 
allowed specific fractions to be characterised for activity. This led to the formation of 





4.7  Small Angle X-ray scattering 
 
Conformation of the quaternary structure of DHDPR enzymes can be found using 
small angle X-ray scattering. This allows determination of the size and shape of 
DHDPR enzymes. To be used as controls, both tetrameric E. coli and dimeric A. 
thaliana DHDPR enzymes were used as references for C. merolae quaternary 






Figure 4.21: Intensity plot (log I vs S) (a) and distance distribution plot (P (R)) (b) for 










Figure 4.22: Intensity plot (log I vs S) (a) and distance distribution plot (P (R)) (b) for 











Figure 4.23: Intensity plot (log I vs S) (a) and distance distribution plot (P (R)) (b) for 
C. merolae DHDPR. 
 
Table 4.3: The parameters for the SAXS analysis. 
Organism Name Rg (Å) Io Porod Volume 
(Å3) 
A. thaliana 35.06±0.47 0.048 128,525 
T. maritima 37.16±0.24 0.049 199,135 
E. coli 39.88±3.59 0.046 241,859 
C. merolae 35.14±0.66 0.021 120,226 
 
C. merolae DHDPR P(R) plot indicates a dimeric structure in solution (Figure 4.23). 






significant skew towards the left side. This indicates that the protein does not have an 
even distribution of mass around the centre of the protein meaning that it likely exists 
in a dimeric formation. Scatter patterns can also can be compared to E. coli and A. 
thaliana controls to deduce which quaternary state the protein conforms to (Table 4.3). 
It’s radius of gyration compared favourably to the A. thaliana dimeric value as 
opposed to the much higher E. coli and T. maritima tetrameric values. This is also 
backed up the Porod volume which is similar to the A. thaliana value. These factors 
indicate that C. merolae DHDPR exists in a dimeric formation. 
 
 
Figure 4.24: GASBOR model for C. merolae (Chi2 fit = 0.25) 
 
These observations are also observed in the ab initio modelling of the scatter data 
(Figure 4.24. A dimeric structure reminiscent of a half an E. coli DHDPR is observed 





Figure 4.25: Possible formations for a dimeric DHDPR. 
 
If C. merolae DHDPR does exist in a dimeric formation, it is uncertain exactly which 
orientation the dimer forms. It could form one of 3 different dimers (Figure 4.25). The 
most likely configuration is the “β-sheet dimer”. In this conformation, two β-sheets 
pair together to form an eight stranded β-sheet. Another possible conformation is 
known as the “loop dimer”. This is formed by two loops that hydrogen bond with 
each other. The other possible dimer is known as the “cross dimer”. This dimer forms 
a diagonal conformation across the former tetramer with hydrogen bonds forming a β-
sheet “sandwich” which has a length half of the full tetrameric equivalent version. 
The last two do not show the features of the SAXS model with a large gap in between 
the two monomers. This is much more indicative of a β-sheet dimer than the other 








4.8  Summary 
 
Phylogenetic tree analysis showed that both red and green algal DHDPR enzymes 
cluster around plant organisms indicating that they may be more closely related to the 
plant type protein than the bacterial. Green alga Chlamydomonas reinhardtii DHDPR 
was found to exist in varying positions on the evolutionary lineage but may exist 
between bacterial and plant type species. Sequence analysis showed that while almost 
all other DHDPR sequences retained residues thought to be critical to catalysis, C. 
reinhardtii did not contain these residues making its mechanism unknown. In the 
quantitative size exclusion experiment, almost all algal species characterised were 
found to exist as dimers. This fits with the phylogenetic tree which indicates that these 
species exist after A. thaliana in the evolutionary lineage. This could indicate an 
evolutionary divergence point between bacterial and plant type DHDPR enzymes. 
 
Kinetic assays showed that was no clear patterns within green algal species with 
varying levels of substrate inhibition along with nucleotide and substrate affinities 
observed. Red and brown algal species were found to act similarly to each other with 
each species observing a similar affinity for each nucleotide with substrate inhibition. 
The exception to this was O. lucimarinus which exhibited an extremely strong affinity 
for NADH but no measurable activity whilst utilising NADPH. In C. merolae 
DHDPR, small angle X-ray scattering showed that the dimeric arrangement is thought 





Chapter 5 - C. reinhardtii DHDPR 
 
5.1  Overview 
 
C. reinhardtii is green alga existing worldwide among soil and fresh water. Due to the 
dimer-tetramer equilibrium of the C. reinhardtii DHDPR and possible position 
between bacteria and plant enzymes in the evolutionary lineage, it may serve as a 
divergent DHDPR enzyme. To establish more information about the properties of C. 
reinhardtii DHDPR, several characterisation techniques were used.  
 
5.2  Purification and Expression 
 
The plasmid was purified transformed into E. coli BL21 DE3 cells using standard lab 
techniques and the enzyme was purified using the techniques described in the 
methods with a 19.7 mg yield from 1.6 L. The protein was stored in “high salt” 20 
mM Tris and 500 mM NaCl buffer and frozen until use. On an SDS PAGE gel, the 
protein shows two separate bands (Figure 5.1. As this process should remove any 
quaternary interactions, the fact that two bands exist shows that a disulfide bond is 
present in solution. 
 
Figure 5.1: SDS-PAGE gel of C. reinhardtii DHDPR in its native form and in the 




5.3  Analytical Ultracentrifugation 
 
AUC was used to more effectively characterise the quaternary state of C. reinhardtii 
DHDPR. This technique allowed the molecular weights of the species in solution to 
be found. 
 
Figure 5.2: Sedimentation of C. reinhardtii DHDPR at 3 different concentrations. 
 
C. reinhardtii DHDPR exists in two quaternary states (Figure 5.2. One peak exists at 
~4.5 S with the other residing at ~6.8 S. These two peaks exist at theoretical 
molecular weights of ~60,000 Da and ~110,000 Da which approximately correspond 
to dimeric and tetrameric species. Interestingly, in the highest concentration of protein, 
a peak is observed at ~9 S which equates to a molecular weight of ~185,000 Da. This 
may indicate the presence of a small amount of hexameric protein in solution, which 
may indicate three dimeric species joining together. This, along with quantitative size 
exclusion, reinforces the idea that C. reinhardtii DHDPR exists in a dimer-tetramer 
equilibrium, with a small amount of possible hexamer at higher concentrations. 
 
The C. reinhardtii DHDPR equilibrium is modified in the presence of reducing agent 
(Figure 5.3). This is also expressed in AUC data in the presence of TCEP. With no 
reducing agent present, a typical dimer-tetramer equilibrium is observed. However, 
when 2 mM TCEP was added, the equilibrium shifts almost exclusively to the dimeric 
form. This has not been observed in any other DHDPR so far making it the first 






Figure 5.3: 0.5 mg/ml of C. reinhardtii DHDPR with and without the presence of 
reducing agent. 
 
It is uncertain how this mechanism occurs. The sequence of C. reinhardtii DHDPR 
contains three cysteine residues instead of the regular two that are conserved in all 
other DHDPR enzymes so far. However, these residues do not appear to be in 
positions that would allow a disulfide dimer interface to occur. It is possible that the 
disulfide interface exists on the outside of the protein and is not naturally involved in 
the protein. Rather, it may exist as a “daisy chain” dimer where disulfide bonds are 
formed on the outside of the protein which may appear in solution as a tetramer or 
even a hexamer depending on protein concertation. 
 
While DHDPS in plants has been known to exist in the chloroplast, the location of 
DHDPR in non-bacterial organisms has not been determined (Ghislain et al., 1990). 
However, the presence of a transit peptide; a key sequence important for protein entry 
into the chloroplast indicates that C. reinhardtii DHDPR exists in the chloroplast. 
This would likely mean that the enzyme would exist in a non-reduced form in vivo as 
opposed to an exclusively dimeric form in the reducing environment of the cytoplasm 
where the bacterial DAP pathway takes place.  
 
5.4  Enzyme Kinetics 
 
To test the kinetic parameters of C. reinhardtii DHDPR, kinetic assays were 




the presence of 2 mM TCEP. This ensures that any changes in kinetics for the reduced 
form of the enzyme are observed (Table 5.1). 
 
Table 5.1: Kinetic parameters for C. reinhardtii DHDPR. 
Buffer Nucleotide Km (mM) Vrel 
(μmol/mg/s) 
Vrel/Km Ki (mM) 
No TCEP NADH 0.45±0.26 0.079±0.033 0.17 0.33±0.33 
No TCEP NADPH 0.035±0.012 0.050±0.0041 1.4 23.54±33.00 
2 mM TCEP NADH 0.45±0.26 0.079±0.033 0.21 0.55±0.33 
2 mM TCEP NADPH 0.015±0.0088 0.072±0.0073 4.74 3.37±1.54 
 
Figure 5.4: Kinetics for C. reinhardtii utilising both NADPH and NADH. Both data 
sets were fitted to a substrate inhibition model.  
 
Figure 5.5: Kinetics for C. reinhardtii in the presence of reducing agent TCEP. Both 





When C. reinhardtii activity is compared between nucleotides, it exhibits a much 
greater rate and substrate affinity whilst utilising NADPH (Figure 5.4). This exhibits a 
nucleotide specificity somewhat like T. maritima DHDPR, however with a much 
higher rate in the presence of NADH. This may indicate that it is more closely related 
to bacteria. However, NADPH may be the nucleotide preference of this algal enzyme 
due to the association with the light reactions in this chloroplast containing organism. 
This may indicate plant-like nucleotide utilisation tendencies. 
 
The kinetic behaviour of the reduced form of the enzyme was tested in the presence of 
the reducing agent TCEP (Figure 5.5). When NADH was used as the nucleotide, both 
buffer conditions gave extremely similar profiles. Affinities were similar in both cases 
however the maximum rate was slightly higher in the presence of no reducing agent. 
However, when NADPH is utilised as the nucleotide, the reverse is observed. In the 
presence of a reducing agent, the observed rate is noticeably higher with a marked 
increase in substrate inhibition compared to the unreduced counterpart. Overall 
however, there is not a great deal of difference between the reduced and unreduced 
forms of the enzyme indicating that the reduced form of the enzyme does not exhibit 
noticeably different enzyme activity. 
 
 
5.5  Small Angle X-ray Scattering 
 
To further characterise the quaternary structure of the protein in the presence of 
reducing agent, small angle X-ray scattering was performed. This allowed further 
confirmation of the quaternary structure of the protein. To ensure that the protein was 
completely reduced without reducing agents negatively affecting the data, the protein 
was treated with reducing agent a few days prior to data collection. Following 
treatment, the reducing agent was removed using SEC 24 hours prior to data 
collection with the sample ran on an SDS PAGE gel to check for reformation of the 






Figure 5.6: Intensity plot (log I vs S) and distance distribution plot (P (R)) for C. 
reinhardtii DHDPR. 
 
Table 5.2: Parameters for SAXS analysis in reducing agent  
Organism Name Rg (Å) Io Porod Volume 
(Å3) 
A. thaliana 35.06±0.47 0.048 128,525 
E. coli 39.88±3.59 0.046 241,859 
C. reinhardtii 33.53±0.51 0.0097 120,825 
 
The C. reinhardtii P(R) plot indicates that the mass of the object is not uniformly 
distributed around the centre of the protein (Figure 5.6). Normally, this would be 






there are multiple peaks and valleys on the right side of the graph. This may indicate 
that the dimer has formed an interesting non-uniform structure. 
 
Like C. merolae DHDPR, C. reinhardtii DHDPR X-ray scatter patterns can be 
compared between bacterial and plant type DHDPR enzymes (Table 5.2). The radius 
of gyration of the reduced form is slightly less than A. thaliana which equilibrates to a 
dimeric quaternary structure. This is backed up by the Porod volumes which show a 
slightly smaller volume than A. thaliana DHDPR which also calculates to half of the 
tetrameric volume. 
 
Table 5.3: Chi2 fit for C. reinhardtii scattering data against the crystal structures of E. 
coli and T. maritima DHDPR and various modifications. 
Organism Name Comparison Structure Chi2 
C. reinhardtii DHDPR E. coli DHDPR Tetramer 0.33 
C. reinhardtii DHDPR E. coli DHDPR β-sheet Dimer 0.26 
C. reinhardtii DHDPR E. coli DHDPR Loop Dimer 0.25 
C. reinhardtii DHDPR E. coli DHDPR Cross Dimer 0.41 
 
To find out which dimer is formed, the scatter patterns were compared to the crystal 
structures for each theoretical dimer (Table 5.3). The best fits are for the β-sheet 
dimer and the Loop dimer, which have similar Chi2 fits to the data. The cross dimer 
appears unlikely due to the improbable configuration of the dimer. The GASBOR 
model appears to resemble the β-sheet dimer due to the perceived monomeric 
arrangement. In any case, it appears that both the C. merolae and C. reinhardtii have a 





Figure 5.7: GASBOR model created from C. reinhardtii DHDPR (Chi2 fit against raw 
data = 0.13) 
 
GASBOR ab initio modelling suggests a very similar dimeric structure to C. merolae 





5.6  Differential Scanning Fluorimetry 
 
To test the thermal stability of C. reinhardtii DHDPR in comparison to other DHDPR 
enzymes, DSF was used. This also allowed comparison when bound to nucleotides as 
well as the substrate analogue, 2,6-pyridinedicarboxylate (PDC). 
 
Table 5.4: DSF data for E. coli and A. thaliana DHDPR 
Organism Name Ligand TmAve (°C) 
E. coli No Ligand 80.28±0.00 
E. coli 1.5 mM NADH 80.96±0.39 
E. coli 1.5 mM NADPH 81.48±0.05 
A. thaliana No Ligand 43.21±0.24 
A. thaliana 1.5 mM NADH 46.43±0.00 
A. thaliana 1.5 mM NADPH 44.22±0.42 
 
 







Figure 5.9: Melt curves for A. thaliana with no ligand and in the presence of 
nucleotide. 
 
To compare with C. reinhardtii DHDPR, the melting points of E. coli and A. thaliana 
DHDPR were taken (Figures 5.8 and 5.9, Table 5.4). These were found to be 80.3°C 
and 43.2°C respectively with no ligand present. With the addition of nucleotide (the 
first ligand that binds to the enzyme), the thermal stability of the protein marginally 
increased by a small amount in both cases. This had been previously observed for T. 
maritima DHDPR (Pearce et al., 2008). What was interesting to note was the presence 
of a small secondary melt curve in E. coli. With no ligand present, a small peak at 
~47°C was observed. The peak was also observed in the nucleotide bound species but 
to a much lesser extent.  
 
Table 5.5: DSF data for C. reinhardtii DHDPR in the presence of no reducing agent  
Ligand TmAve (°C) Secondary TmAve (°C) 
No Ligand 45.9±0.3 72.5±0.0 
1.5 mM NADH 47.1±0.2 76.2±0.2 
1.5 mM NADPH 47.7±1.4 74.7±0.1 
PDC 48.3±2.1  
PDC, 1.5 mM NADH 55.4±2.1  






Figure 5.10: Melt curves for C. reinhardtii DHDPR in the presence of no ligand along 
with two different nucleotides. 
 
 
Figure 5.11: Melt curves for C. reinhardtii DHDPR in the presence of substrate 
analogue PDC in addition to two different nucleotides. 
 
This data can be compared with C. reinhardtii DHDPR to understand its stability 
(Table 5.5). Like in E. coli, it contains two melt peaks (Figure 5.10). The smaller first 
peak was found to have a Tm of 45.9 °C. This was followed by a much larger second 
peak with a Tm of 72.5°C. This observation indicates that the enzyme undergoes a 
two-step melting process. However, addition of various ligands changes the melting 
profile. Addition of nucleotide increased the thermal stability of the initial peak by 
1.2 °C and 1.8 °C degrees for NADH and NADPH respectively. A 3.8 °C and a 
2.2 °C increase in stability was also observed in the second larger peak. 
 
The addition of substrate analogue PDC greatly increases the stability of the enzyme 
(Figure 5.11). With PDC present, a 2.4 °C increase from the initial ligand unbound 




two. This is also observed with addition of both NADH and PDC with a 9.5 °C 
increase from the ligand unbound value but no secondary peak. When NADPH is 
used as the substrate, the melt curve reverts to a typical two-step curve with a small 
peak at 46.1°C followed by a normal sized peak at 66.7°C. This second peak value 
exhibits a significantly increased melting temperature, indicating that the protein may 
have a higher affinity towards NADPH as its substrate. The two-step binding 
mechanism also indicates that the binding mechanisms may not be the same for each 
nucleotide.  
 
Table 5.6: DSF data for C. reinhardtii DHDPR in the presence of 2 mM TCEP 
Ligand TmAve (°C) Secondary TmAve (°C) 
No Ligand 62.9±0.0  
1.5 mM NADH 48.1±0.9 70.6±0.7 
1.5 mM NADPH 49.9±1.1 71.2±0.1 
PDC 49.3±0.6  
PDC, 1.5 mM NADH 55.5±1.0  
PDC, 1.5 mM NADPH 46.5±1.2 65.7±0.3 
 
 
Figure 5.12: Melt curves for C. reinhardtii DHDPR in presence of reducing agent 






Figure 5.13: Melt curves for C. reinhardtii DHDPR in the presence of reducing agent 
with substrate analogue PDC in addition to two different nucleotides. 
 
The addition of TCEP influences the melting profile of the protein (Table 5.6). With 
the presence of 2mM TCEP forming a reduced species, the first peak remains in 
approximately the same position, albeit with a smaller peak height that is not 
quantified in analysis (Figure 5.12). The second peak is decreased by 9.6°C. NADH 
and NADPH bound species also lost stability by 5.6°C and 8.0°C respectively. These 
values indicate that the reduced dimeric species has a lower stability than the native C. 
reinhardtii DHDPR species. In the presence of PDC alone and PDC in solution with 
NADH, a one-step melt curve is observed, similar to the unreduced species. Thermal 
stabilities under these conditions were within 1 °C of their unreduced counterparts. 
The two-step PDC and NADPH utilisation is also present in the reduced form of the 
enzyme with only ~1°C difference between the native enzyme (Figure 5.13). These 
values indicate that there is little difference in the binding mechanism between the 











5.7  Conclusions 
 
5.7.1  Proposed DHDPR Evolutionary Lineage  
With the discovery that C. reinhardtii DHDPR exists as both a dimer and a tetramer 
in solution, a possible evolutionary mechanism can be inferred (Figure 5.14). With 
tetrameric and dimeric DHDPR enzymes existing, it is likely that at some point in the 
evolutionary lineage, a divergence similar to DHDPS occurred from the bacterial to 
the plant form. If C. reinhardtii DHDPR exists in both the bacterial tetramer and plant 
dimer forms, it is possible that it is the divergence point between these species. This is 
corroborated by the fact that C. reinhardtii DHDPR exists on the evolutionary lineage 
exactly between bacterial and plant DHDPR species in one of the proposed 
evolutionary lineages. This makes C. reinhardtii DHDPR an important species in the 
evolution of the protein.  
 
This discovery is interesting when compared to the proposed DHDPS evolution 
mechanism. The split between the dimeric and plant type tetramer in DHDPS was 
found to occur in the lycophytic S. moellendorffii DHDPS. It appears to occur at a 
different positon in DHDPR with SMO DHDPR thought to exist as a dimer 
(unpublished data). As they are both members of the same pathway, the fact that the 








Figure 5.14: This image shows the proposed evolutionary pathway for DHDPR. On 
the left is an E. coli DHDPR which represents the tetrameric bacterial structure. On 
the right side is a proposed dimeric DHDPR representing the plant type structure. In 
the middle is the C. reinhardtii DHDPR equilibrium between tetrameric and dimeric 
forms of the enzyme. 
 
5.7.2  Summary 
AUC data showed that C. reinhardtii DHDPR exists in an equilibrium between dimer 
and tetramer. It was also shown that the protein contains a novel disulfide-dependent 
dimer interface with the reducing agent TCEP forcing an exclusively dimeric species 
in solution. Kinetic assays showed that the reduced form of the enzyme did not 
exhibit greatly altered kinetics, indicating that the reduced form of the enzyme is still 
viable. DSF data indicated that that both nucleotide and the substrate analogue PDC 
were found to increase the stability of the protein. PDC was also found to induce a 
one-step melt curve in the presence of NADH in both reduced and unreduced forms of 
the enzyme but NADPH was found to restore the typical two-step melt profile. This 
equilibrium along with its location in the evolutionary lineage could mean that C. 
reinhardtii DHDPR exists as the “divergence” point between bacterial and plant 








Chapter 6 – Conclusions 
 
The main aim of this project was to characterise the evolutionary lineage of DHDPS 
and DHDPR. Firstly, the evolutionary lineage of DHDPS was investigated through 
the characterisation of Selaginella moellendorffii DHDPS, which exists in a substrate-
mediated equilibrium between dimeric and tetrameric forms. The allosteric inhibitor 
lysine pushed the equilibrium towards the dimeric form, whereas the substrate 
pyruvate pushed the equilibrium towards the tetrameric form. This equilibrium may 
be the evolutionary divergence point between dimeric and the tetrameric plant 
quaternary structure. Along with the already discovered dimer-bacterial tetramer 
equilibrium, this allows the construction of a proposed DHDPS evolutionary pathway. 
 
A similar evolutionary difference in DHDPR is also proposed. In this study, several 
red, brown and green algal DHDPR enzymes were found to exist as a dimeric species. 
This reinforced the idea that the DHDPR enzymes from these organisms existed after 
those of plants on the evolutionary lineage, proposing them as dimers. This included 
the discovery of C. reinhardtii DHDPR whose location on the evolutionary lineage 
along with its dimer-tetramer equilibrium indicates that it may be a divergence point 
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